Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0000882796-25-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | 2025-12-12 | BCRX | Gayer Charles K | Pres, CCO | F - Tax | $7.57 | -8,181 | 418.8K | -2% | -$61.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | F | D | 8,181 | $7.57 | 418,827 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person. |